NTRK3 and neuroblastoma: Neuroblastoma patients whose tumors have elevated TrkA [40] or TrkC [40, 41] expression have a better prognosis, than those who do not, whereas those with higher TrkB and BDNF levels have a particularly poor prognosis [42].